105 related articles for article (PubMed ID: 17176635)
21. Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys.
Aceto MD; Dewey WL; Portoghese PS; Takemori AE
Eur J Pharmacol; 1986 Apr; 123(3):387-93. PubMed ID: 3720824
[TBL] [Abstract][Full Text] [Related]
22. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
Dykstra LA; Gmerek DE; Winger G; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
[TBL] [Abstract][Full Text] [Related]
23. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
24. Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.
Chen XH; Liu-Chen LY; Tallarida RJ; Geller EB; de Riel JK; Adler MW
Neurochem Res; 1996 Nov; 21(11):1363-8. PubMed ID: 8947926
[TBL] [Abstract][Full Text] [Related]
25. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
[TBL] [Abstract][Full Text] [Related]
26. Alterations in nociception and morphine antinociception in mice fed a high-fat diet.
Nealon CM; Patel C; Worley BL; Henderson-Redmond AN; Morgan DJ; Czyzyk TA
Brain Res Bull; 2018 Apr; 138():64-72. PubMed ID: 28684345
[TBL] [Abstract][Full Text] [Related]
27. Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception.
Katsuyama S; Mizoguchi H; Kuwahata H; Komatsu T; Nagaoka K; Nakamura H; Bagetta G; Sakurada T; Sakurada S
Eur J Pain; 2013 May; 17(5):664-75. PubMed ID: 23138934
[TBL] [Abstract][Full Text] [Related]
28. Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphine.
Noble F; Roques BP
Neurosci Lett; 1995 Feb; 185(2):75-8. PubMed ID: 7746508
[TBL] [Abstract][Full Text] [Related]
29. Antagonism of the response rate-decreasing effects of meperidine and morphine by beta-funaltrexamine and naltrexone in squirrel monkeys.
Hughes CE; Dykstra LA
Drug Alcohol Depend; 1997 May; 45(3):197-206. PubMed ID: 9179521
[TBL] [Abstract][Full Text] [Related]
30. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
31. Neonatal naltrindole and handling differently affect morphine antinociception in male and female rats.
Fernández B; Alberti I; Kitchen I; Viveros MP
Pharmacol Biochem Behav; 1999 Dec; 64(4):851-5. PubMed ID: 10593209
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
[TBL] [Abstract][Full Text] [Related]
33. The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.
Davis RL; Buck DJ; Saffarian N; Stevens CW
J Neuroimmunol; 2007 May; 186(1-2):141-9. PubMed ID: 17475341
[TBL] [Abstract][Full Text] [Related]
34. Altering dietary levels of protein or vitamins and minerals does not modify morphine-induced analgesia in male rats.
Kanarek RB; D'Anci KE; Przypek JM; Mathes WF
Pharmacol Biochem Behav; 1999 Feb; 62(2):203-8. PubMed ID: 9972684
[TBL] [Abstract][Full Text] [Related]
35. Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism.
Jiang Q; Seyed-Mozaffari A; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1995 May; 273(2):680-8. PubMed ID: 7752070
[TBL] [Abstract][Full Text] [Related]
36. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
Gmerek DE; Woods JH
J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071
[TBL] [Abstract][Full Text] [Related]
37. Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2001 May; 297(2):590-6. PubMed ID: 11303047
[TBL] [Abstract][Full Text] [Related]
38. Reversal by beta-funaltrexamine and 16-methyl cyprenorphine of the antinociceptive effects of opioid agonists in the mouse and guinea-pig.
Hayes AG; Birch PJ
Neuropharmacology; 1988 Aug; 27(8):813-6. PubMed ID: 3216959
[TBL] [Abstract][Full Text] [Related]
39. Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats.
Adams JU; Andrews JS; Hiller JM; Simon EJ; Holtzman SG
Life Sci; 1987 Dec; 41(26):2835-44. PubMed ID: 2826950
[TBL] [Abstract][Full Text] [Related]
40. Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.
Michaels CC; Holtzman SG
Pharmacol Biochem Behav; 2007 Apr; 86(4):784-96. PubMed ID: 17459462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
